MYC and glioma: The ethyl ester form of the FTO inhibitor Meclofenaic (MA2) inhibits FTO and enhances the effect of the chemotherapeutic drug temozolom by targeting the MYC-miR-155/23a cluster-MXI1 feedback circuit in gliomas anti-tumor effects (45) (Table 2).